Ken Griffin
EIKN

Ken Griffin’s Eikon Therapeutics EIKN Stock Holding History

Ken Griffin’s Portfolio EIKN Stock Details EIKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.28M Buy
+310,000
New +$4.14M ﹤0.01% 5090

Other funds holding EIKN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ken Griffin's EIKN Position: Q1 2026 in Review

Ken Griffin opened a new position in Eikon Therapeutics (EIKN) in Q1 2026: 310,000 shares worth $3.28M. The stake represents ﹤0.01% of the portfolio and ranks #5090 among its holdings.

52 funds tracked by Wall St. Rank hold EIKN as of Q1 2026.

  • Ken Griffin held 310,000 shares of Eikon Therapeutics worth $3.28M as of Q1 2026.
  • Eikon Therapeutics was a new Ken Griffin position in Q1 2026.
  • Eikon Therapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #5090 holding.
  • 52 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.